BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26261151)

  • 41. Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate?
    Satter EK; Metcalf JS; Maize JC
    J Cutan Pathol; 2006 Nov; 33(11):756-9. PubMed ID: 17083697
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pterygopalatine ganglion syndrome].
    Tebloev IK; Grinberg LM; Kalashnikov IuD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(6):826-30. PubMed ID: 952147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of the sphenoid sinusitis with neuro-ophthalmologic syndromes].
    Du X; Cai Q; Ma Z; Tao Z; Wu Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 16(2):78-9. PubMed ID: 15510636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features of scleromyxoedema in an Afro-Caribbean man.
    Ufodiama CE; Tynes G; Unwala R
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30665930
    [No Abstract]   [Full Text] [Related]  

  • 45. Scleromyxedema with myopathy was successfully treated by thalidomide.
    Wu MY; Hong JB; Yang CC; Hu SL; Liao YH
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):189-90. PubMed ID: 18435730
    [No Abstract]   [Full Text] [Related]  

  • 46. Reactive pseudotumoural papular mucinosis: a new clinicopathological presentation?
    Sáez-Rodríguez M; Rodríguez-Martín M; Carnerero-Rodríguez A; Sidro-Sarto M; Pérez-Robayna N; García-Bustínduy M; Herrera AM; Cabrera AN
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):245-6. PubMed ID: 18211426
    [No Abstract]   [Full Text] [Related]  

  • 47. Scleromyxedema.
    Yang Y; Chen H; Zhang W; Sun JF
    Indian J Dermatol Venereol Leprol; 2016; 82(6):738-739. PubMed ID: 26858056
    [No Abstract]   [Full Text] [Related]  

  • 48. Granulomatous scleromyxedema: case report and literature review.
    Shlyankevich J; Stetsenko GY; George E; Lantz DM; Burwick NR; Vary JC
    Am J Dermatopathol; 2015 Mar; 37(3):240-5. PubMed ID: 24247576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome".
    River Y; Levy I; Gilead L; Orbach H; Almog Y
    Neurology; 1996 Jun; 46(6):1778-9. PubMed ID: 8649597
    [No Abstract]   [Full Text] [Related]  

  • 50. [Neurologic disorders in the postural compression syndrome].
    Iunakh OB
    Sov Med; 1988; (8):122-3. PubMed ID: 3201317
    [No Abstract]   [Full Text] [Related]  

  • 51. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
    Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
    Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scleroderma-like acute renal crisis in a patient with scleromyxedema.
    Gwinner W; Erdbruegger U; Mengel M; Hafer C; Kittner J; Witte T; Voelker B; Haller H
    Nephrol Dial Transplant; 2007 Jul; 22(7):2063-7. PubMed ID: 17389621
    [No Abstract]   [Full Text] [Related]  

  • 53. Resident Rounds part III: scleromyxedema: a rare disorder associated with a monoclonal gammopathy.
    Mandell JA; Glick JB; Kaur RR
    J Drugs Dermatol; 2014 May; 13(5):619-20. PubMed ID: 24809891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse Indurated Skin.
    Lim VZ; Tey HL
    Ann Acad Med Singap; 2016 Aug; 45(8):379-80. PubMed ID: 27683746
    [No Abstract]   [Full Text] [Related]  

  • 55. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
    do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
    Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
    [No Abstract]   [Full Text] [Related]  

  • 56. [Nervous and mental disorders in patients with chronic alcoholic pancreatitis].
    Gel'fand VB; Nikolaev GV; Danilov MV; Svanidze GSh; Vikhorev AV
    Klin Med (Mosk); 1990 Apr; 68(4):111-4. PubMed ID: 2370768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neurological manifestation of multiple cholesterol embolization syndrome: Value of MRI diffusion sequence].
    Devoize JL; Sztark G; Mehou-Loko A; Foo Cheung L; Joyes B
    Rev Neurol (Paris); 2013 Nov; 169(11):913-6. PubMed ID: 23523018
    [No Abstract]   [Full Text] [Related]  

  • 58. Thought and mood disorders: a neurologic perspective.
    Lechtenberg R
    Compr Ther; 1992 May; 18(5):11-6. PubMed ID: 1643831
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neurogenic disorders in extracerebral malignant growths].
    Müller E; Spanke O; Lehmann I
    Med Klin; 1969 Aug; 64(33):1470-5. PubMed ID: 5805799
    [No Abstract]   [Full Text] [Related]  

  • 60. Radiology update in neuro-ophthalmology.
    Pula JH; Daily J; DeSanto J
    Curr Opin Ophthalmol; 2011 Nov; 22(6):451-7. PubMed ID: 21946306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.